186 related articles for article (PubMed ID: 25954015)
1. A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development.
Ellery PE; Maroney SA; Cooley BC; Luyendyk JP; Zogg M; Weiler H; Mast AE
Blood; 2015 Jun; 125(26):4078-84. PubMed ID: 25954015
[TBL] [Abstract][Full Text] [Related]
2. Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice.
Maroney SA; Siebert AE; Martinez ND; Rasmussen M; Peterson JA; Weiler H; Lincoln J; Mast AE
J Thromb Haemost; 2023 Mar; 21(3):639-651. PubMed ID: 36696221
[TBL] [Abstract][Full Text] [Related]
3. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
4. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
[TBL] [Abstract][Full Text] [Related]
5. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
[TBL] [Abstract][Full Text] [Related]
6. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
[TBL] [Abstract][Full Text] [Related]
7. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.
Pedersen B; Holscher T; Sato Y; Pawlinski R; Mackman N
Blood; 2005 Apr; 105(7):2777-82. PubMed ID: 15598816
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor is required for cerebrovascular development in mice.
Maroney SA; Westrick RJ; Cleuren AC; Martinez ND; Siebert AE; Zogg M; Ginsburg D; Weiler H; Mast AE
Blood; 2021 Jan; 137(2):258-268. PubMed ID: 32735640
[TBL] [Abstract][Full Text] [Related]
9. Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency.
Castillo MM; Yang Q; Zhan M; Pan AY; Lawlor MW; Mast AE; Sood R
Blood Adv; 2019 Feb; 3(3):489-498. PubMed ID: 30755437
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
11. Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.
Winckers K; Thomassen S; Ten Cate H; Hackeng TM
PLoS One; 2017; 12(2):e0168273. PubMed ID: 28158181
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
13. Protection against thrombosis in mice lacking PAR3.
Weiss EJ; Hamilton JR; Lease KE; Coughlin SR
Blood; 2002 Nov; 100(9):3240-4. PubMed ID: 12384423
[TBL] [Abstract][Full Text] [Related]
14. Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Nielsen LV; Johansen PB; Hermit MB; Petersen LC; Mast AE
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3927-31. PubMed ID: 22355108
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.
Huang ZF; Higuchi D; Lasky N; Broze GJ
Blood; 1997 Aug; 90(3):944-51. PubMed ID: 9242522
[TBL] [Abstract][Full Text] [Related]
16. A dual thrombin receptor system for platelet activation.
Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp.
Shimizu S; Ogawa T; Takezawa K; Tojima I; Kouzaki H; Shimizu T
Am J Rhinol Allergy; 2015; 29(4):235-42. PubMed ID: 26163243
[TBL] [Abstract][Full Text] [Related]
18. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.
Hamilton JR; Cornelissen I; Mountford JK; Coughlin SR
Atherosclerosis; 2009 Aug; 205(2):427-32. PubMed ID: 19217621
[TBL] [Abstract][Full Text] [Related]
20. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
